Needham & Company LLC Reiterates “Buy” Rating for Axsome Therapeutics (NASDAQ:AXSM)
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Needham & Company LLC in a research note issued on Tuesday,Benzinga reports. They presently have a $153.00 target price on the stock. Needham & Company LLC’s target price suggests a potential upside of 39.41% from the company’s previous close. […]
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Needham & Company LLC in a research note issued on Tuesday,Benzinga reports. They presently have a $153.00 target price on the stock. Needham & Company LLC’s target price suggests a potential upside of 39.41% from the company’s previous close. […]
